newsfilter
← Latest News
GlobeNewswire·

Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026

SALT LAKE CITY, April 16, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostic testing and precision medicine, announced that it will share six abstracts, including two podium